K. Hoffman

发表

Psychological distress in long-term survivors of adult-onset cancer: results from a national survey.

K. Hoffman, E. McCarthy, C. Recklitis, 2009, Archives of internal medicine.

Clinical Investigation : Genitourinary Cancer Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy : Results From a Randomized Trial

D. Kuban, S. McGuire, Andrew K. Lee, 2014 .

Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, European urology.

Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy.

W. Woodward, Xiaochun Wang, T. Pan, 2012, International journal of radiation oncology, biology, physics.

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Jean L Wright, R. Jagsi, T. Whelan, 2018, Practical radiation oncology.

Considerations for observational research using large data sets in radiation oncology.

Ronald C. Chen, Ya-Chen Tina Shih, Reshma Jagsi, 2014, International journal of radiation oncology, biology, physics.

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

W. Woodward, K. Hunt, T. Buchholz, 2011, Breast Cancer Research and Treatment.

Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications

S. Kaplan, S. Greenfield, S. Phillips, 2016, Medical care.

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

D. Kuban, S. McGuire, Andrew K. Lee, 2017, Advances in radiation oncology.

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

T. Choueiri, K. Hoffman, B. Mahal, 2016, Brachytherapy.

Proton radiotherapy for breast cancer

W. Woodward, K. Hoffman, F. Poenisch, 2021 .

Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?

W. Woodward, T. Buchholz, K. Hoffman, 2013, The British journal of radiology.

Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study.

M. Cooperberg, S. Kaplan, S. Greenfield, 2019, The Journal of urology.

External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis

K. Hoffman, A. Zietman, T. Hong, 2008, Cancer.

Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.

W. Woodward, Xiaochun Wang, G. Babiera, 2015, Practical radiation oncology.

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

Nikhil G Thaker, Lajos Pusztai, Karen E Hoffman, 2015, SpringerPlus.

Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.

W. Woodward, K. Hunt, T. Buchholz, 2016, International journal of radiation oncology, biology, physics.

Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients

G. Babiera, K. Hunt, K. Hoffman, 2013, Annals of Surgical Oncology.

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

K. Hunt, T. Buchholz, K. Hoffman, 2012, Breast Cancer Research.

CLINICAL CASE The Debate Over Prostate Cancer Screening Guidelines

K. Hoffman, P. Nguyen, P. Nguyen, 2011 .

Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy

G. Gladish, A. Rao, K. Hoffman, 2019, Journal of cardiovascular imaging.

Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging.

Jim C Hu, T. Choueiri, K. Hoffman, 2015, Urologic oncology.

Refusal of curative radiation therapy and surgery among patients with cancer.

Ming-Hui Chen, Jim C Hu, T. Choueiri, 2014, International journal of radiation oncology, biology, physics.

Cancer-specific outcomes among young adults without health insurance.

Ming-Hui Chen, Jim C Hu, T. Choueiri, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

US radiation oncology practice patterns for posttreatment survivor care.

K. Hoffman, M. Huq, James B. Yu, 2016, Practical radiation oncology.

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

Jim C Hu, T. Choueiri, K. Hoffman, 2011, JAMA.

Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer

D. Kuban, K. Hess, S. McGuire, 2020, JAMA network open.

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.

Jim C Hu, T. Choueiri, K. Hoffman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer.

P. Catalano, T. Choueiri, K. Hoffman, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method.

K. Hoffman, P. Parikh, K. Goodman, 2016, Practical radiation oncology.

Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study.

R. Mak, K. Hoffman, E. McCarthy, 2011, International journal of radiation oncology, biology, physics.

Genitourinary Cancer Survivorship Management

D. Kuban, K. Hoffman, John W. Davis, 2015 .

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

Jim C Hu, T. Choueiri, K. Hoffman, 2016, BJU international.

Endorectal MRI for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy

D. Kuban, S. McGuire, Andrew K. Lee, 2014 .

Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.

Daniel J. Lee, M. Cooperberg, S. Kaplan, 2018, Practical radiation oncology.

Patient Reported Comparative Effectiveness of Contemporary Intensity Modulated Radiation Therapy Versus External Beam Radiation Therapy of the Mid 1990s for Localized Prostate Cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, Urology practice.

The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, Urology.

The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.

M. Cooperberg, S. Kaplan, S. Greenfield, 2015, European urology.

Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation

D. Kuban, S. McGuire, Andrew K. Lee, 2010 .

Costs and Complications after a Diagnosis of Prostate Cancer Treated with Time-Efficient Modalities: an Analysis of National Medicare Data.

Ya-Chen Tina Shih, D. Kuban, K. Hess, 2020, Practical radiation oncology.

Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

D. Kuban, S. McGuire, Andrew K. Lee, 2012, European journal of cancer.

Development of a standard survivorship care plan template for radiation oncologists.

Ronald C. Chen, K. Hoffman, T. Showalter, 2016, Practical radiation oncology.

Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.

Ronald C. Chen, A. D'Amico, Ming-Hui Chen, 2011, The Journal of urology.

Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States.

W. Chan, K. Hoffman, D. Lairson, 2019, Urologic oncology.

Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.

W. Woodward, G. Hortobagyi, K. Hunt, 2021, International journal of radiation oncology, biology, physics.

Travel distance and stereotactic body radiotherapy for localized prostate cancer

Jim C Hu, K. Hoffman, B. Mahal, 2018, Cancer.

Prognosis for patients with metastatic breast cancer who achieve a no‐evidence‐of‐disease status after systemic or local therapy

Gary J Whitman, Karen E Hoffman, Naoto T Ueno, 2015, Cancer.

Influence of Geography on Prostate Cancer Treatment.

Ya-Chen Tina Shih, Benjamin D. Smith, K. Hoffman, 2020, International journal of radiation oncology, biology, physics.

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.

T. Choueiri, K. Hoffman, B. Mahal, 2017, International journal of radiation oncology, biology, physics.

Active surveillance in prostate cancer: new efforts, new voices, new hope

K. Hoffman, Jeri Kim, Spyridon Panagiotis Basourakos, 2017, BJU international.

Oncology: Prostate/Testis/Penis/Urethra Interpretation of Domain Scores on the EPICdHow Does the Domain Score Translate into Functional Outcomes?

M. Cooperberg, S. Kaplan, S. Greenfield, 2022 .

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Lei Dong, D. Kuban, S. McGuire, 2013, International journal of radiation oncology, biology, physics.

Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.

Ronald C. Chen, A. Trofimov, K. Hoffman, 2010, International journal of radiation oncology, biology, physics.

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

D. Kuban, S. McGuire, K. Hoffman, 2019, Cancer.

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

D. Kuban, S. McGuire, Andrew K. Lee, 2013, Cancer.

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?

D. Kuban, T. Pugh, S. McGuire, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of Curative-Intent Treatment for Breast Cancer Patients Presenting with Sternal or Mediastinal Involvement

W. Woodward, H. Kuerer, T. Buchholz, 2017 .

Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers.

D. Kuban, S. McGuire, T. Bathala, 2020, International journal of radiation oncology, biology, physics.

Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.

A. D'Amico, Ming-Hui Chen, K. Hoffman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

G. Hortobagyi, K. Hoffman, F. Holmes, 1995, Cancer Chemotherapy and Pharmacology.

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial

D. Kuban, S. McGuire, Andrew K. Lee, 2016, American journal of clinical oncology.

Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

W. Woodward, H. Kuerer, T. Buchholz, 2019, International journal of radiation oncology, biology, physics.

The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial

D. Brachman, K. Hoffman, R. Valicenti, 2014, Quality of Life Research.

Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer

W. Woodward, Benjamin D. Smith, K. Hoffman, 2021, Advances in radiation oncology.

Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging

W. Woodward, W. Chan, Benjamin D. Smith, 2022, Breast Cancer Research and Treatment.

Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.

T. Choueiri, K. Hoffman, B. Mahal, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Healing of vulvo-vaginal radionecrosis following revascularization.

K. Hoffman, N. Horowitz, A. Russell, 2007, Gynecologic oncology.

Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma

P. Tamboli, K. Hoffman, L. Levy, 2017, BJU international.

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer

Ronald C. Chen, A. D'Amico, Ming-Hui Chen, 2012, BJU international.

A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

W. Woodward, G. Babiera, T. Buchholz, 2017, International journal of radiation oncology, biology, physics.

A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction

W. Woodward, H. Kuerer, Benjamin D. Smith, 2017, Annals of Surgical Oncology.

Management of advanced primary urethral carcinomas

R. Vikram, K. Hoffman, Charles C. Guo, 2014, BJU international.

Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, Prostate Cancer and Prostatic Diseases.

Impact of evidence‐based clinical guidelines on the adoption of postmastectomy radiation in older women

S. Shirvani, T. Buchholz, Benjamin D. Smith, 2011, Cancer.

Radiation Therapy for Pediatric Central Nervous System Tumors

K. Hoffman, T. Yock, 2009, Journal of child neurology.

Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.

W. Woodward, G. Babiera, Jinzhong Yang, 2019, Practical radiation oncology.

Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: A population-based study: Milano MT, Li H, Gail MH, et al (Univ of Rochester Med Ctr, NY; Natl Insts of Health, Rockville, MD) J Clin Oncol 28:5088-5096, 2010

K. Hoffman, 2011 .

Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy.

T. Buchholz, K. Hoffman, E. Mittendorf, 2012, The Lancet. Oncology.

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

W. Woodward, G. Hortobagyi, K. Hunt, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.

A. D'Amico, Ming-Hui Chen, K. Hoffman, 2009, International journal of radiation oncology, biology, physics.

Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer

K. Hoffman, F. Feng, P. Orio, 2016, Journal of contemporary brachytherapy.

Declining use of brachytherapy for the treatment of prostate cancer.

Andrew G. Lee, D. Kuban, K. Hoffman, 2013, Brachytherapy.

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment

M. Cooperberg, S. Kaplan, S. Greenfield, 2014, Cancer.

Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial.

D. Kuban, S. McGuire, K. Hoffman, 2019, International journal of radiation oncology, biology, physics.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, Practical radiation oncology.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.

D. Kuban, S. McGuire, Andrew K. Lee, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy

Shuangge Ma, K. Hunt, K. Hoffman, 2017, JAMA oncology.

American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns

H. Kuerer, G. Babiera, K. Hunt, 2012, Annals of Surgical Oncology.

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

K. Hunt, T. Buchholz, K. Hoffman, 2009, Breast Cancer Research.

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy.

A. D'Amico, Jim C Hu, T. Choueiri, 2010, Urology.

Marital status and survival in patients with cancer.

Ming-Hui Chen, Jim C Hu, T. Choueiri, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

A. D'Amico, Ming-Hui Chen, Jim C Hu, 2015, BJU international.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, JAMA.

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients.

Ming-Hui Chen, T. Choueiri, K. Hoffman, 2015, International journal of radiation oncology, biology, physics.

Physician variation in management of low-risk prostate cancer: a population-based cohort study.

Robert J Volk, Yu Shen, Karen E Hoffman, 2014, JAMA internal medicine.

Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

M. Cooperberg, S. Kaplan, S. Greenfield, 2013, Journal of comparative effectiveness research.

Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?

D. Kuban, S. McGuire, Andrew K. Lee, 2011, International journal of radiation oncology, biology, physics.

Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.

K. Hoffman, 2012, Seminars in radiation oncology.

Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study.

Ronald C. Chen, K. Hoffman, J. Rosenman, 2012, International journal of radiation oncology, biology, physics.

Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction.

A. D'Amico, P. Kantoff, Ming-Hui Chen, 2012, International journal of radiation oncology, biology, physics.

The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.

M. Cooperberg, S. Kaplan, S. Greenfield, 2016, The Journal of urology.

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer.

A. D'Amico, Ming-Hui Chen, Jim C Hu, 2013, Brachytherapy.

Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, Urologic oncology.

Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center

D. Kuban, E. Holliday, S. McGuire, 2016, Journal of Radiation Oncology.

National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009.

K. Hoffman, B. Mahal, J. Efstathiou, 2015, Clinical genitourinary cancer.

Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.

A. D'Amico, Jim C Hu, T. Choueiri, 2014, Clinical genitourinary cancer.

Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy.

D. Kuban, S. McGuire, T. Bathala, 2020, Brachytherapy.

Expanding Implementation of ACOSOG Z0011 in Surgeon Practice

H. Kuerer, K. Hunt, K. Hoffman, 2018, Clinical breast cancer.

Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials

H. Kuerer, Benjamin D. Smith, K. Hoffman, 2019, Annals of Surgical Oncology.

Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

S. Lipsitz, Jim C Hu, X. Gu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer

K. Hoffman, J. Harris, 2009 .

Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.

L. Potters, K. Hoffman, A. Zietman, 2013, Journal of oncology practice.

Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care

Benjamin D. Smith, K. Hoffman, A. Koong, 2022, Cancer medicine.

Radiotherapy clinical trial enrollment during the COVID-19 pandemic

Benjamin D. Smith, K. Hoffman, A. Koong, 2020, Acta oncologica.

Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance

D. Kuban, Andrew K. Lee, K. Hoffman, 2016, BJU international.

Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial

G. Hortobagyi, M. Ross, H. Kuerer, 2011, Annals of Surgical Oncology.

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.

A. Kishan, A. D'Amico, L. Potters, 2020, International journal of radiation oncology, biology, physics.

Knowledge‐based planning for the radiation therapy treatment plan quality assurance for patients with head and neck cancer

A. Garden, L. Court, K. Hoffman, 2022, Journal of applied clinical medical physics.

Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.

A. D'Amico, K. Hoffman, A. Ng, 2010, The Journal of urology.

Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.

K. Hoffman, D. Penson, A. Morgans, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data

K. Hoffman, Simon P. Kim, J. Huo, 2017, Cancer.

Association of Transforming Growth Factor &bgr; Polymorphism C−509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

W. Woodward, T. Buchholz, Benjamin D. Smith, 2018, JAMA oncology.

UC San Francisco UC San Francisco Previously Published Works Title Contemporary prevalence of pretreatment urinary , sexual , hormonal , and bowel dysfunction : Defining the population at risk for harms of prostate cancer treatment

M. Cooperberg, S. Kaplan, S. Greenfield, 2014 .

Fate of manuscripts rejected from the Red Journal.

Karen E Hoffman, Reshma Jagsi, Anthony L Zietman, 2015, International journal of radiation oncology, biology, physics.

Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.

W. Woodward, G. Hortobagyi, K. Hunt, 2015, JAMA oncology.

Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period.

Karen E Hoffman, Reshma Jagsi, E. Holliday, 2015, International journal of radiation oncology, biology, physics.

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer

W. Woodward, T. Buchholz, Benjamin D. Smith, 2018, Advances in radiation oncology.

Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives.

Jing Jiang, Benjamin D. Smith, K. Hoffman, 2019, Journal of oncology practice.

Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.

W. Woodward, T. Buchholz, Benjamin D. Smith, 2012, International journal of radiation oncology, biology, physics.

External-beam accelerated partial breast irradiation using multiple proton beam configurations.

W. Woodward, Xiaodong Zhang, Xiaochun Wang, 2011, International journal of radiation oncology, biology, physics.

Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.

Matthew Koshy, Usama Mahmood, Benjamin D. Smith, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort

D. Kuban, S. McGuire, K. Hoffman, 2018, BJU international.

Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.

R. Jagsi, D. Gomez, Benjamin D. Smith, 2017, International journal of radiation oncology, biology, physics.

Current Practice Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States

R. Jagsi, D. Gomez, Benjamin D. Smith, 2017 .

Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program

W. Woodward, Benjamin D. Smith, K. Hoffman, 2023, Breast.

Physician Variation inManagement of Low-Risk Prostate Cancer A Population-Based Cohort Study

D. Kuban, Jing Jiang, Benjamin D. Smith, 2014 .

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.

T. Choueiri, K. Hoffman, B. Mahal, 2018, European urology.

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.

K. Hoffman, B. Mahal, F. Feng, 2017, European urology focus.

Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy

H. Kuerer, G. Babiera, K. Hunt, 2012, Annals of Surgical Oncology.

Racial disparities in guideline-concordant cancer care and mortality in the United States

R. Jagsi, D. Gomez, Benjamin D. Smith, 2018, Advances in radiation oncology.

Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.

Daniel J. Lee, M. Cooperberg, S. Greenfield, 2018, European urology.

Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, JAMA.

How Improved Local-Regional Therapy Impacts Survival

T. Buchholz, K. Hoffman, 2010 .

Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, The Journal of urology.

Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, JAMA oncology.

Quantification of beam complexity in intensity-modulated radiation therapy treatment plans.

Rajat J Kudchadker, Weiliang Du, Sang Hyun Cho, 2014, Medical physics.

National sociodemographic disparities in the treatment of high‐risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

T. Choueiri, K. Hoffman, B. Mahal, 2016, Cancer.

Case Report Healing of vulvo-vaginal radionecrosis following revascularization

K. Hoffman, N. Horowitz, A. Russell, 2007 .

Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Urologic oncology.

Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer.

D. Kuban, T. Pugh, S. McGuire, 2012 .

Risk of hospitalisation after primary treatment for prostate cancer

Benjamin D. Smith, K. Hoffman, S. Giordano, 2017, BJU international.

Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.

S. Shirvani, Jing Jiang, T. Buchholz, 2016, International Journal of Radiation Oncology, Biology, Physics.

Regional differences in recommended cancer treatment for the elderly

Benjamin D. Smith, K. Hoffman, S. Giordano, 2016, BMC Health Services Research.

Improvement in Prostate Cancer Survival Over Time: A 20-Year Analysis

D. Kuban, S. McGuire, Andrew K. Lee, 2012, Cancer journal.

Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

K. Hoffman, R. Volk, L. Lowenstein, 2021, BMJ Open.

Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States

T. Choueiri, K. Hoffman, B. Mahal, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.

Ya-Chen Tina Shih, Jeffrey M Albert, Yu Shen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.

Jim C Hu, K. Hoffman, C. Dinney, 2017, European urology focus.

Population‐based analysis of occult primary breast cancer with axillary lymph node metastasis

W. Woodward, K. Hunt, T. Buchholz, 2010, Cancer.

Racial Disparities in the Management of African American Men With Intermediate- to High-Risk Prostate Cancer

A. D'Amico, Jim C Hu, T. Choueiri, 2014 .

Clinical Investigation : Genitourinary Cancer PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

D. Kuban, S. McGuire, Andrew K. Lee, 2022 .

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

D. Kuban, Andrew K. Lee, K. Hoffman, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline

K. Hoffman, H. Sandler, J. Efstathiou, 2019, The Journal of urology.

The implications of ageing and life expectancy in prostate cancer treatment

K. Hoffman, John W. Davis, R. Volk, 2016, Nature Reviews Urology.

Management of prostate cancer in elderly men.

K. Hoffman, S. Bian, 2013, Seminars in radiation oncology.

Radiation therapy modalities in prostate cancer.

K. Hoffman, T. Pugh, J. Johnson, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase II Trial.

W. Woodward, Benjamin D. Smith, K. Hoffman, 2020, International journal of radiation oncology, biology, physics.

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects

W. Woodward, Benjamin D. Smith, K. Hoffman, 2018, Cancers.

The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3‐Year Results from the CEASAR Study

Daniel J. Lee, M. Cooperberg, S. Greenfield, 2017, The Journal of urology.

Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.

W. Woodward, Benjamin D. Smith, K. Hoffman, 2022, International journal of radiation oncology, biology, physics.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

D. Kuban, S. McGuire, K. Hoffman, 2018, International journal of radiation oncology, biology, physics.

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

D. Kuban, S. McGuire, Andrew K. Lee, 2013, Brachytherapy.

Current clinical presentation and treatment of localized prostate cancer in the United States.

D. Kuban, Andrew K. Lee, K. Hoffman, 2014, The Journal of urology.

The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

A. D'Amico, Jim C Hu, T. Choueiri, 2014 .

THE INFLUENCE OF PSYCHOSOCIAL CONSTRUCTS ON THE ADHERENCE TO ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER IN A PROSPECTIVE, POPULATION‐BASED COHORT: PD28‐04

M. Cooperberg, K. Hoffman, D. Penson, 2017 .

National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study

K. Hoffman, B. Mahal, F. Feng, 2016, Cancer.

Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.

K. Hoffman, B. Mahal, F. Feng, 2016, International journal of radiation oncology, biology, physics.

Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

D. Kuban, K. Hoffman, S. Cantor, 2022, MDM policy & practice.

Five‐year outcomes from a prospective comparative effectiveness study evaluating external‐beam radiotherapy with or without low‐dose‐rate brachytherapy boost for localized prostate cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Cancer.

Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.

K. Hoffman, B. Mahal, F. Feng, 2017, Urologic oncology.

Impact of Chemotherapy Sequencing on Local-Regional Failure Risk in Breast Cancer Patients Undergoing Breast-Conserving Therapy

G. Hortobagyi, M. Ross, H. Kuerer, 2013, Annals of surgery.

Lymph node-positive prostate cancer: the benefit of local therapy.

D. Kuban, K. Hoffman, 2013, Oncology.

Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, The Journal of urology.

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation

W. Woodward, G. Babiera, T. Buchholz, 2014, SpringerPlus.

Adjuvant therapy for elderly patients with resected gastric adenocarcinoma

C. Earle, K. Hoffman, L. Kachnic, 2012, Cancer.

Screening Breast MR Imaging in Women with a History of Chest Irradiation

K. Hoffman, G. Whitman, 2012 .

Screening Breast MR Imaging in Women with a History of Chest Irradiation: Sung JS, Lee CH, Morris EA, et al (Memorial Sloan-Kettering Cancer Ctr, NY) Radiology 259:65-71, 2011§

K. Hoffman, G. Whitman, 2012 .

Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.

Jing Jiang, Benjamin D. Smith, K. Hoffman, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla.

W. Woodward, K. Hunt, T. Buchholz, 2014, Practical radiation oncology.

The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

D. Kuban, S. McGuire, Andrew K. Lee, 2012, American journal of clinical oncology.

CLINICAL TRIAL ENROLLMENT IN A MULTIDISCIPLINARY PROSTATE CANCER

K. Hoffman, A. Guadagnolo, 2017 .

Local recurrence map to guide target volume delineation after radical prostatectomy.

D. Kuban, S. McGuire, K. Hoffman, 2014, Practical radiation oncology.

Radical prostatectomy or radiotherapy for high‐ and very high‐risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment

D. Kuban, K. Hoffman, P. Allen, 2019, BJU international.

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size.

A. D'Amico, P. Kantoff, Jim C Hu, 2011, International journal of radiation oncology, biology, physics.

Incidence and determinants of 1-month mortality after cancer-directed surgery.

A. D'Amico, Jim C Hu, T. Choueiri, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data.

Vojtech Huser, Charles Mayo, Todd McNutt, 2016, International journal of radiation oncology, biology, physics.

Meta-analysis of the Impact of Androgen Deprivation Therapy on Cardiovascular Death in Patients with Prostate Cancer

Jim C Hu, T. Choueiri, K. Hoffman, 2011 .

Long-term Survival and Competing Causes of Death in Men with Stage I Seminoma

Ming-Hui Chen, K. Hoffman, A. Ng, 2010 .

Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.

Daniel J. Lee, M. Cooperberg, S. Kaplan, 2018, International journal of radiation oncology, biology, physics.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, The Journal of urology.

Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer

K. Hoffman, J. Huo, B. Smith, 2017, Prostate Cancer and Prostatic Diseases.

Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?

W. Woodward, H. Kuerer, K. Hoffman, 2016, International journal of radiation oncology, biology, physics.

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce.

Jim C Hu, T. Choueiri, K. Hoffman, 2018, The American journal of medicine.

Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.

K. Hunt, Jing Jiang, T. Buchholz, 2014, International journal of radiation oncology, biology, physics.

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.

A. D'Amico, Ming-Hui Chen, M. Kattan, 2013, Urology.

Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, The Journal of urology.

The debate over prostate cancer screening guidelines.

K. Hoffman, P. Nguyen, 2011, The virtual mentor : VM.

More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, The Journal of urology.

Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer

T. Choueiri, K. Hoffman, F. Feng, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence and determinants of 1-month mortality after cancer-directed surgery.

A. D'Amico, K. Hoffman, B. Mahal, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial.

D. Kuban, S. McGuire, Andrew K. Lee, 2016, International journal of particle therapy.

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

Jim C Hu, T. Choueiri, K. Hoffman, 2016 .

Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.

M. Cooperberg, S. Greenfield, K. Hoffman, 2017, European urology.

Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing.

Diane D. Liu, W. Woodward, Benjamin D. Smith, 2021, International journal of radiation oncology, biology, physics.

Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients

D. Kuban, S. McGuire, K. Hoffman, 2013, Prostate Cancer and Prostatic Disease.

Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.

K. Hoffman, 2012, Seminars in Radiation Oncology.

Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.

Benjamin D. Smith, K. Hoffman, P. Allen, 2014, Journal of Clinical Oncology.

Local recurrence map to guide target volume delineation after radical prostatectomy.

D. Kuban, S. McGuire, K. Hoffman, 2014, Practical radiation oncology.

Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Prostate Cancer and Prostatic Diseases.

Combination of Radiotherapy and Short-Term Androgen Blockade with Abiraterone Acetate plus Prednisone for Men with High and Intermediate Risk Localized Prostate Cancer.

M. Harrison, K. Hoffman, A. Armstrong, 2020, International journal of radiation oncology, biology, physics.

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.

T. Choueiri, K. Hoffman, B. Mahal, 2019, European urology.